News
-
ACLA Statement to Senate Finance on Rural Health Care
... -
Laboratory Developed Tests: Ground Zero in the Push Towards Personalized Medicine
For the many patients who suffer from rare or complex conditions, the certainty that comes from knowing a diagnosis and moving forward with a treatment plan is one of the most powerful – and personal – moments in health care. That certainty and clarity comes from the ground-breaking innovations underway in bringing new laboratory developed tests to millions of Americans across the country. LaboratoryContinue Reading »... -
ACLA Comments on Medicaid Proposed Access Rule
... -
Recent NILA report highlights harmful impacts of misguided PAMA implementation on labs and seniors
A report recently published by the National Independent Laboratory Association (NILA), highlights the ways in which the Protecting Access to Medicare Act (PAMA) is undermining the nation’s clinical laboratory infrastructure. Specifically, the report demonstrates the harmful impacts the legislation has already had on community and regional labs across the country and the threats current PAMA implementation poses to seniors’ access to lifesaving clinical tests.Continue Reading »... -
Patient Advocates, Providers, Laboratories and Diagnostic Manufacturers Urge Congressional Leaders to Modernize Regulation of Clinical Diagnostics
More than 80 Groups Unite for the First Time to Call for Legislative Reform Washington, D.C. – Leading health care companies and organizations representing patients, providers, laboratories and diagnostic manufacturers called on Senate and House leaders to advance legislation that would reform and modernize the process for bringing innovative diagnostics and clinical laboratory tests to market. In a letter to the Chairmen andContinue Reading »... -
Stakeholder Letter on Diagnostic Reform
... -
ACLA Comments to NGS on Draft LCD on Administrative MAAAs and PLAs
... -
ACLA Urges Summary Judgment from District Court on Lawsuit Against HHS
Lawsuit targets HHS’ unlawful implementation of 2014 Medicare legislation, regulation that would jeopardize beneficiaries’ access to critical lab services Washington, D.C. – With millions of Medicare beneficiaries facing potential shortages in critical laboratory tests and diagnostics, the American Clinical Laboratory Association (ACLA) continued the push for summary judgment in its lawsuit against the U.S. Department of Health and Human Services (HHS) for failing toContinue Reading »... -
ACLA VS. AZAR – Reply in Support of Motion for Summary Judgment
... -
ACLA Supportive of CMS Revisions to National Coverage Determination on the Use of Next Generation Sequencing in Cancer
(Washington, D.C.) – The American Clinical Laboratory Association (ACLA) expressed support today for revisions made by the Centers for Medicare and Medicaid Services (CMS) to the final National Coverage Determination (NCD) released today on Next Generation Sequencing (NGS) for Medicare Beneficiaries with Advanced Cancer. The association and other stakeholders submitted extensive comments to the agency on the proposed NCD to ensure that the policyContinue Reading »...
